Avanos Medical, Inc. (NYSE: AVNS) is a player in the healthcare sector, specifically within the medical devices industry. With a current market capitalization of $672.61 million, this US-based company is..
Nurix Therapeutics, Inc. (NASDAQ: NRIX) is capturing attention in the biotechnology sector, primarily due to its promising drug development pipeline and a potential upside of 86.22%, as indicated by current..
Cronos Group Inc. (NASDAQ: CRON) is a name that resonates with many investors interested in the burgeoning cannabis market. As a key player in the healthcare sector, specifically within the..
For investors seeking to tap into the burgeoning medical devices sector, Butterfly Network, Inc. (NYSE: BFLY) presents an intriguing opportunity. With its market cap sitting at $1.18 billion, this healthcare..
Embecta Corp. (EMBC), a stalwart in the healthcare sector, operates within the medical instruments and supplies industry. The company is renowned for its diabetes care solutions, including pen needles, syringes,..
Zevra Therapeutics, Inc. (NASDAQ: ZVRA) has been turning heads in the biotechnology sector with its focus on rare diseases and promising product pipeline. With a market capitalization of $511.74 million,..
Akebia Therapeutics, Inc. (NASDAQ: AKBA), a biopharmaceutical company, is capturing investor attention with its substantial potential upside of 233.33%, making it a noteworthy candidate for those interested in the healthcare..
HealthStream, Inc. (HSTM), a key player in the healthcare sector specializing in health information services, offers a compelling investment opportunity with an estimated potential upside of 42.99%. As of the..
Stoke Therapeutics, Inc. (STOK), a burgeoning name in the biotechnology sector, is captivating investor interest with its promising pipeline of genetic treatments and a notable potential upside of 17.3%. The..
Capricor Therapeutics, Inc. (NASDAQ: CAPR), a frontrunner in the biotechnology sector, is making waves with its ambitious aim to revolutionize treatment methodologies for diseases with unmet medical needs, particularly Duchenne..
RxSight, Inc. (RXST), a promising player in the medical technology arena, presents a unique opportunity for investors seeking exposure to the healthcare sector, specifically in the innovative medical devices space...
CareDx, Inc. (CDNA), a prominent player in the healthcare diagnostics and research sector, has caught the eye of investors with its robust growth prospects and a noteworthy potential upside of..
InnovAge Holding Corp. (NASDAQ: INNV), a key player in the healthcare sector, specializes in providing comprehensive medical and ancillary services tailored for seniors, ensuring they can live independently while receiving..
Collegium Pharmaceutical, Inc. (NASDAQ: COLL), a notable player in the healthcare sector, has captured investor attention with its robust pipeline of pain management medications and promising financial metrics. With a..
For investors looking to navigate the dynamic field of healthcare technology, Talkspace, Inc. (NASDAQ: TALK) presents a compelling opportunity. Positioned within the burgeoning sector of virtual behavioral healthcare, Talkspace offers..
OrthoPediatrics Corp. (NASDAQ: KIDS), a pioneering player in the healthcare sector focused on pediatric orthopedic solutions, stands at a pivotal juncture for investors with a potential upside of 34.91%. This..
Owens & Minor, Inc. (NYSE: OMI), a notable player in the healthcare sector specializing in medical distribution, presents a compelling narrative for investors with its standout potential upside of 94.29%...
For investors with an eye on the biotechnology sector, uniQure N.V. (QURE) is a fascinating opportunity. Headquartered in Amsterdam, this Dutch company is a prominent player in the healthcare industry,..
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX), a Massachusetts-based clinical-stage pharmaceutical company, is causing a stir in the healthcare sector with its focus on cutting-edge treatments for neurodegenerative diseases and endocrine conditions...
Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) presents a compelling investment opportunity in the biotechnology sector, with a potential upside of 14.37%, according to current analyst ratings. With a market capitalization..
